Full name
CLINICAL RESEARCH CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CLINICAL RESEARCH CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. POZNAŃSKA 3 / 31, 60-848 POZNAŃ
TAX ID7811882084
Rate company:
CLINICAL RESEARCH CENTER SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID7811882084
KRS0000444805
Share capital5,100.00 zł
address
UL. POZNAŃSKA 3 / 31, 60-848 POZNAŃ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
7811882084
REGON
302247333
KRS
0000444805
Legal form
limited liability company
Register Address
UL. POZNAŃSKA 3 / 31, 60-848 POZNAŃ
Date of registration in KRS
2012-12-31
Date of commencement of economic activity
2012-12-31
Act signature
RDF/628526/24/502
Pkd codes
72.11.Z - Research and experimental development on biotechnology
21.10.Z - Manufacture of basic pharmaceutical substances
21.20.Z - Manufacture of medicines and other pharmaceutical products
46.46.Z - Wholesale of pharmaceutical goods
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
58.12.Z - Publishing of directories and registers (e.g. street, phone directory)
72.19.Z - Other research and experimental development on natural sciences and engineering
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.90.E - Other human health activities notelsewhere classified
96.09.Z - Other personal service activities not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL72 1050 1520 1000 0090 9984 0549 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | -2,4 | -3,5 | -52,2 | -1387,3 |
EBITDA | -3 | -2,1 | -47,6 | -2203,9 |
Short time liabilities | 39,2 | 1,8 | 32,1 | 1685,7 |
Equity capital | -13,4 | -16,8 | -68,9 | -311,1 |
Operating profit (EBIT) | -3 | -2,1 | -47,6 | -2203,9 |
Assets | 26,8 | 25,5 | 79,2 | 210,7 |
Net profit (loss) | -2,4 | -3,5 | -52,2 | -1387,3 |
Cash | 1,5 | 0,6 | 32 | 5490,8 |
Net income from sale | 9,6 | 11,2 | 160,2 | 1337,1 |
Liabilities and provisions for liabilities | 40,2 | 42,3 | 148,1 | 250,5 |
Working assets | 26 | 24,7 | 78,4 | 217,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 18 | 20,9 | 75,7 | 54,8 |
Equity capital to total assets | -49,8 | -65,8 | -87,1 | -21,3 |
Gross profit margin | -25 | -31,5 | -32,6 | -1,1 |
EBITDA Margin | -30,8 | -18,5 | -29,7 | -11,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 1490 | 59 | 73 | 14 |
Current financial liquidity indicator | 0.647725522518158 | 8.819788932800293 | 2.297050952911377 | -6,5 |
Net dept to EBITDA | -12.345985412597656 | -18.806869506835938 | -1.7219107151031494 | 17,1 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.